Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This study aims to explore the efficacy and safety of intra- arterial infusion of gemcitabine
and oxaliplatin in locally advanced pancreatic cancer. This protocol is overseen by the Fudan
University Institutional Review Board which has Federal Wide Assurance through the U.S.
Department of Health & Human Services (Approved: April 25, 2002).